Brief: Xbrane Says FDA To Decide On October 21st On Lucentis

Xbrane Biopharma AB

23/05/2025 14:07

May 23 (Reuters) - Xbrane Biopharma AB XBRANE.ST:

FDA HAS NOW COMMUNICATED OCTOBER 21ST 2025 AS BSUFA DATE (DECISION DATE)

Source text: ID:nMFN9Mlyrd

Further company coverage: XBRANE.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))